Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Jeffrey S Martini is Chief Scientific Officer at Palvella Therapeutics. OQRO lists 19 transactions filed with the SEC under this name, the latest on Nov 12, 2026, each linked to the official Form 4.
Chief Scientific Officer
Disclosures on record
19
Companies involved
1
Palvella TherapeuticsPVLA
19 disclosures · Nov 2026 · 13 sold
Nov 11, 2026Sold~$271Kdisclosed Nov 12
DetailsOfficial recordNov 10, 2026Sold~$274Kdisclosed Nov 12
DetailsNov 10, 2026Sold~$250Kdisclosed Nov 12
DetailsOfficial recordNov 11, 2026Sold~$243Kdisclosed Nov 12
DetailsOfficial recordNov 10, 2026Sold~$239Kdisclosed Nov 12
DetailsOfficial recordNov 11, 2026Sold~$201Kdisclosed Nov 12
DetailsOfficial recordNov 11, 2026Sold~$189Kdisclosed Nov 12
DetailsOfficial recordNov 10, 2026Sold~$138Kdisclosed Nov 12
DetailsOfficial recordNov 11, 2026Sold~$101Kdisclosed Nov 12
DetailsOfficial recordNov 10, 2026Sold~$93Kdisclosed Nov 12
DetailsOfficial recordNov 10, 2026Sold~$34Kdisclosed Nov 12
DetailsOfficial recordNov 11, 2026Sold~$34Kdisclosed Nov 12
DetailsOfficial recordNov 10, 2026Sold~$16Kdisclosed Nov 12
DetailsOfficial recordNov 11, 20266,250disclosed Nov 12
DetailsOfficial recordNov 10, 20261,984disclosed Nov 12
DetailsOfficial recordNov 11, 20266,250disclosed Nov 12
DetailsOfficial recordNov 10, 20264,266disclosed Nov 12
DetailsOfficial recordNov 10, 20261,984disclosed Nov 12
DetailsOfficial recordNov 10, 20264,266disclosed Nov 12
DetailsOfficial recordJeffrey S Martini has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
In SEC filings since 2026: no open-market purchase is on record; the latest open-market sale is from 2026.
Palvella Therapeutics (PVLA), from 2026 to 2026: 0 purchases and 13 sales.
Jeffrey S Martini reported 0 open-market purchases and 13 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Jeffrey S Martini has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
Jeffrey S Martini reported 0 open-market purchases and 13 sales since 2026; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $2.08M13×13 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.